Core Viewpoint - Faraday Future (FF) announced a strategic investment in Qualigen Therapeutics, Inc. (QLGN) and initiated collaboration in Crypto and Web3 business, with QLGN's stock price experiencing a significant increase post-announcement [1][4][10]. Investment Details - The strategic investment led by FF is expected to exceed $41 million, pending shareholder approval and other conditions [4][10]. - FF's founder and Co-CEO, Jia Yueting, is investing $4 million as a cornerstone investor and will lock his shares for two years [4][14]. - After the investment, FF and Jia Yueting will collectively hold approximately 62% of QLGN [14]. Business Strategy - The investment is part of FF's "dual-flywheel and dual-bridge" strategy, aiming to integrate Web2 with Web3 and AI with Crypto, maximizing value for shareholders [15]. - QLGN will be renamed CXC10 and will focus on developing six major products under the Crypto "three-horse carriage" business model [16]. Product Development - The FX Super One vehicle was showcased, featuring the EAI Space, which offers a personalized, multi-modal, immersive experience for users [6][9]. - The vehicle is set to have its first unit roll off the production line in the U.S. by the end of the year, with deliveries in the Middle East expected in November [6][8]. Financial Performance - The C10 Treasury has completed approximately $10 million in crypto asset allocation, achieving a floating profit of about 7% as of September 18 [17].